Mondes Film Tablet

Description

Things to consider before using

Do not use if:

If

• • If you have an allergy against any of the substances contained in the drug (active substance or auxiliary substances),
  • Do not use this drug if you have severe liver failure.

 

Use with caution if

Efficacy and reliability have not been proven in children under the age of 15. If you have impaired kidney function, use Mondes carefully. The effectiveness of Mondes in the treatment of acute asthma attacks has not been proven. Therefore, it should not be used to treat acute asthma attacks; patients should be offered treatment with appropriate drugs. Mondes treatment can be continued during acute exacerbations.

Although the dose of the co-supplied inhale corticosteroid can be gradually reduced under medical supervision, oral or inhale corticosteroid therapy should not be abruptly discontiloyed and replaced with Mondes.

Patients who are known to be sensitive to aspirin should avoid the use of aspirin or non-steroidal anti-inflammatory agents when using  Mondes.

In a clinical pharmacology study, desloratadine taken with alcohol did not increase the performance-disrupting effects of tablet alcohol.

Desloratadine in the content of Mondes can rarely cause sleepiness in some people and impair their ability to use tools and machines.

Eozinofli

Patients receiving montelukast/desloratadine rarely have clinical findings consistent with Churg-Strauss Syndrome, a type of vasculitis treated with systemic eozinof and sometimes systemic corticosteroids, as in patients undergoing montelukast treatment. This condition is usually associated with the reduction of the dose of systemic corticosteroids. Physicians should be careful about eozinofitis, vasculitis rash, worsening pulmonary symptoms, cardiac complications and/or neuropathy in patients.

Although no causal relationship has been detected between the use of montelukast and the conditions defined, caution and appropriate clinical observation are recommended during the reduction of systemic corticosteroids in patients taking montelukast/desloratadine.

Neuropsychiatric events were reported in adult, anelesan and pediatric patients using montelukast/desloratadine. Post-marketing data reported disorders such as agitation, aggressive behavior or feeling hostility, anxiety, depression, dream abnormalities, hallucinations, insomnia, restlessness, mobility, sleepwalking, suicidal thoughts and behavior (including suicide attempt) and tremor during the use of montelukast/desloratadine. It was determined that there was a consistent relationship between the clinical characteristics of some post-marketing reports related to montelukast/desloratadine and adverse effects.

Patients and doctors should be careful about neuropsychiatric events. Patients should be warned that they should inform their doctor if they encounter such changes. In case of such conditions, doctors should carefully consider the risks and benefits of the drug in order to continue mondes treatment.

“If these fits are necessary for you, even in any period in the past, please consult your doctor.”

Use of Mondes with food and drink

MONDES can be taken alone or with food. The film tablet is taken by ingestion with a sufficient amount of water as a whole.

Pregnancy

Consult your doctor or pharmacist before using the drug.

Mondes is not recommended for use in pregnant women.

If you find out that you are pregnant during your treatment, consult your doctor or pharmacist immediately.

Lactation

Consult your doctor or pharmacist before using the drug.

If you are breastfeeding, inform your doctor. Breastfeeding women should not use MONDES.

Vehicle use

No studies have been carried out to determine the effect of Mondes on vehicle and machine use. However, it should be kept in mind that dizziness and sleepiness may be seen during treatment when using vehicles and machines. Doctors need to warn you to get sick.

Important information about some of the auxiliary substances contained in Mondes

If you are not hypersensitive to the auxiliary substances contained in Mondes, no negative effects due to these substances are expected.

Lactose warning

If you have previously been told by your doctor that you have intolerance to certain sugars, please contact your doctor before taking this medical product.

Sodium warning

This medicinal product contains less than 1 mmol (23 mg) of sodium per dose; i.e. it is essentially sodium-free

Sunset yellow contained in the coating of Mondes may cause allergic reactions.

Use in combination with other drugs

In multi-dose interaction studies, ketoconazole, erythromycin, azithromycin, fluoxetine and symmethine did not cause a significant change in plasma concentrations of desloratadine. Food and grapefruit juice have no effect on the disposition of desloratadine. Desloratadine has no known interaction with other drugs.

Interactions associated with Montelukast

During treatment with Montelukast, other drugs can usually be taken. When used in concur with other treatments, there is no increase in undesirable effects. However, drugs used simultaneously may change each other’s effects and/or side effects. Therefore, you should inform your doctor about the medications taken before you start using Mondes.

• • Drugs used in epilepsy, such as phenobarbital, phenytoin and carbamazepine, can reduce the effects of Mondes.
  • Rifampisin (used to treat tuberculosis and some infections) can reduce the effects of Mondes.
  • Its use in combination with thousand and one-thousand-year-old grass (yellow cantaron) and products containing this plant can reduce the effects of Mondes.